SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001047469-17-002280
Filing Date
2017-04-03
Accepted
2017-04-03 07:00:28
Documents
6
Effectiveness Date
2017-04-03

Document Format Files

Seq Description Document Type Size
1 DEFA14A a2231656zdefa14a.htm DEFA14A 33434
2 G226575.JPG g226575.jpg GRAPHIC 7033
3 G103136BGI001.GIF g103136bgi001.gif GRAPHIC 87646
4 G103136BGI002.GIF g103136bgi002.gif GRAPHIC 53958
5 G103136BGI003.GIF g103136bgi003.gif GRAPHIC 100069
6 G103136BGI004.GIF g103136bgi004.gif GRAPHIC 20615
  Complete submission text file 0001047469-17-002280.txt   406303
Mailing Address 2000 SIERRA POINT PARKWAY SUITE 500 BRISBANE CA 94005
Business Address 2000 SIERRA POINT PARKWAY SUITE 500 BRISBANE CA 94005 6502389600
Innoviva, Inc. (Filer) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-30319 | Film No.: 17732252
SIC: 2834 Pharmaceutical Preparations